109 related articles for article (PubMed ID: 22687411)
1. Investigation of transport mechanism of exendin-4 across Madin Darby canine kidney cell monolayers.
Wang M; Sun B; Feng J; Zhang H; Liu B; Li C; Chen Y; Zhang Y; Kong W
Biol Pharm Bull; 2012; 35(5):745-52. PubMed ID: 22687411
[TBL] [Abstract][Full Text] [Related]
2. Permeability of exendin-4-loaded chitosan nanoparticles across MDCK cell monolayers and rat small intestine.
Wang M; Zhang Y; Sun B; Sun Y; Gong X; Wu Y; Zhang X; Kong W; Chen Y
Biol Pharm Bull; 2014; 37(5):740-7. PubMed ID: 24789997
[TBL] [Abstract][Full Text] [Related]
3. Intestinal transport of 3,6'-disinapoylsucrose, a major active component of Polygala tenuifolia, using Caco-2 cell monolayer and in situ rat intestinal perfusion models.
Chen Y; Liu X; Pan R; Zhu X; Steinmetz A; Liao Y; Wang N; Peng B; Chang Q
Planta Med; 2013 Oct; 79(15):1434-9. PubMed ID: 24043590
[TBL] [Abstract][Full Text] [Related]
4. Absorption mechanism of oxymatrine in cultured Madin-Darby canine kidney cell monolayers.
Xiong XH; Huang LH; Zhong YM; Cheng XG; Cen MF; Wang GX; Zang LQ; Wang SJ
Pharm Biol; 2016 Oct; 54(10):2168-75. PubMed ID: 26983455
[TBL] [Abstract][Full Text] [Related]
5. Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability.
Madgula VL; Avula B; Reddy V L N; Khan IA; Khan SI
Planta Med; 2007 Apr; 73(4):330-5. PubMed ID: 17372866
[TBL] [Abstract][Full Text] [Related]
6. In vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers.
Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
Drug Dev Ind Pharm; 2008 Mar; 34(3):279-88. PubMed ID: 18363143
[TBL] [Abstract][Full Text] [Related]
7. Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport.
Dahlgren D; Roos C; Lundqvist A; Tannergren C; Sjöblom M; Sjögren E; Lennernäs H
Int J Pharm; 2018 Oct; 549(1-2):239-248. PubMed ID: 30055302
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.
Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A
Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048
[TBL] [Abstract][Full Text] [Related]
9. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662
[TBL] [Abstract][Full Text] [Related]
10. Absorption enhancement study of astragaloside IV based on its transport mechanism in caco-2 cells.
Huang CR; Wang GJ; Wu XL; Li H; Xie HT; Lv H; Sun JG
Eur J Drug Metab Pharmacokinet; 2006; 31(1):5-10. PubMed ID: 16715776
[TBL] [Abstract][Full Text] [Related]
11. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
[TBL] [Abstract][Full Text] [Related]
12. Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: assessment of molecular weight dependence and demonstration of transport routes.
Lindmark T; Schipper N; Lazorová L; de Boer AG; Artursson P
J Drug Target; 1998; 5(3):215-23. PubMed ID: 9606011
[TBL] [Abstract][Full Text] [Related]
13. Effect of permeability enhancers on paracellular permeability of acyclovir.
Ates M; Kaynak MS; Sahin S
J Pharm Pharmacol; 2016 Jun; 68(6):781-90. PubMed ID: 27061718
[TBL] [Abstract][Full Text] [Related]
14. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions.
Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ
Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157
[TBL] [Abstract][Full Text] [Related]
15. MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening.
Irvine JD; Takahashi L; Lockhart K; Cheong J; Tolan JW; Selick HE; Grove JR
J Pharm Sci; 1999 Jan; 88(1):28-33. PubMed ID: 9874698
[TBL] [Abstract][Full Text] [Related]
16. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy.
Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
J Pharm Sci; 1997 Jul; 86(7):779-85. PubMed ID: 9232516
[TBL] [Abstract][Full Text] [Related]
17. Epithelial transport of noscapine across cell monolayer and influence of absorption enhancers on in vitro permeation and bioavailability: implications for intestinal absorption.
Chougule MB; Patel AR; Patlolla R; Jackson T; Singh M
J Drug Target; 2014 Jul; 22(6):498-508. PubMed ID: 24731057
[TBL] [Abstract][Full Text] [Related]
18. Intestinal absorption of miltefosine: contribution of passive paracellular transport.
Ménez C; Buyse M; Dugave C; Farinotti R; Barratt G
Pharm Res; 2007 Mar; 24(3):546-54. PubMed ID: 17252190
[TBL] [Abstract][Full Text] [Related]
19. Elucidation of Transport Mechanism of Paeoniflorin and the Influence of Ligustilide, Senkyunolide I and Senkyunolide A on Paeoniflorin Transport through Mdck-Mdr1 Cells as Blood-Brain Barrier in Vitro Model.
Hu PY; Liu D; Zheng Q; Wu Q; Tang Y; Yang M
Molecules; 2016 Mar; 21(3):300. PubMed ID: 26950101
[TBL] [Abstract][Full Text] [Related]
20. Transepithelial transport of aliphatic carboxylic acids studied in Madin Darby canine kidney (MDCK) cell monolayers.
Cho MJ; Adson A; Kezdy FJ
Pharm Res; 1990 Apr; 7(4):325-31. PubMed ID: 2114019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
